Goldman Sachs maintains Sell on AstraZeneca (NYSE: AZN).Analyst Keyur Parekh tells clients there is no view the bank is willing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE